We are a team of industry-leading experts across R&D, production, regulation, and commercialization, with deep experience bringing fermentation products to market. At Demetrix, we are pioneering the study and production of the more than 100 rare cannabinoids and their interactions with the human body.
Our current product pipeline focuses on sustainably and reliably producing high-purity, rare cannabinoids backed by science for pharmaceutical and consumer applications.